Which has grown faster, ARWR or PODD?

Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus PODD at 25.13%.

Is ARWR or PODD more profitable?

PODD runs the higher net margin — ARWR at -47.79% versus PODD at 12.29%.

How have ARWR and PODD total returns compared?

Over the past 10 years, ARWR delivered 23.56% and PODD delivered 13.11% annualized total return. Past performance doesn't predict future results.

Arrowhead Pharmaceuticals, Inc. (ARWR) vs Insulet Corp. (PODD)

A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARWR

Arrowhead Pharmaceuticals, Inc.

$8.78B

$62.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

PODD

Insulet Corp.

$9.39B

$135.62HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ARWR vs PODD

growth of $100 · dividends reinvested · last 10y

ARWR +755.3% (+23.9%/yr)PODD +249.6% (+13.3%/yr)ARWR compounded faster over this window

ARWR PODD

ARWR vs PODD: by the numbers

•PODD is the larger company ($9.39B vs $8.78B market cap).
•PODD is profitable (12.29% net margin) while ARWR runs a net loss (-47.79%).
•ARWR grew revenue faster over the past five years (44.14% vs 25.13% CAGR).

Metrics side by side

Valuation

Metric	ARWR	PODD
P/E ratio	N/A	25.35
Forward P/E	N/A	20.85
PEG ratio	N/A	0.25
P/S ratio	13.12	3.08
P/B ratio	18.87	6.61
EV / EBITDA	N/A	15.78
FCF yield	N/A	3.18%

Profitability

Metric	ARWR	PODD
Gross margin	100.00%	71.08%
Operating margin	11.86%	16.89%
Net margin	-47.79%	12.29%
ROE	-68.73%	26.39%
ROIC	-12.12%	16.04%

Growth (annualized)

Metric	ARWR	PODD
Revenue CAGR (5Y)	44.14%	25.13%
EPS CAGR (5Y)	N/A	99.91%
Total return CAGR (5Y)	0.75%	-13.93%

Frequently asked

Which has grown faster, ARWR or PODD?: Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus PODD at 25.13%.
Is ARWR or PODD more profitable?: PODD runs the higher net margin — ARWR at -47.79% versus PODD at 12.29%.
How have ARWR and PODD total returns compared?: Over the past 10 years, ARWR delivered 23.56% and PODD delivered 13.11% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ARWR analysis Full PODD analysis Interactive comparison tool

Dig into the metrics

Insulet P/E ratio Arrowhead Pharmaceuticals ROE Insulet ROE Arrowhead Pharmaceuticals operating margin Insulet operating margin Arrowhead Pharmaceuticals revenue growth Insulet revenue growth Arrowhead Pharmaceuticals free cash flow Insulet free cash flow

Arrowhead Pharmaceuticals & Insulet appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.